Kiniksa Pharmaceuticals Cash from Operations (TTM) Analysis

Kiniksa Pharmaceuticals Ltd (KNSA)

17.61 -0.25 (-1.40%) USD | NASDAQ | Apr 25, 16:00

17.62 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	13.30M
September 30, 2023	-2.60M
June 30, 2023	42.47M
March 31, 2023	38.39M
December 31, 2022	5.807M
September 30, 2022	-1.501M
June 30, 2022	-92.06M
March 31, 2022	-123.02M
December 31, 2021	-126.30M
September 30, 2021	-148.60M
June 30, 2021	-154.42M
March 31, 2021	-144.86M
December 31, 2020	-136.53M

Date	Value
September 30, 2020	-119.51M
June 30, 2020	-114.46M
March 31, 2020	-126.91M
December 31, 2019	-158.37M
September 30, 2019	-161.84M
June 30, 2019	-153.06M
March 31, 2019	-129.30M
December 31, 2018	-81.01M
September 30, 2018	-76.75M
June 30, 2018	-67.21M
March 31, 2018	-59.51M
December 31, 2017	-50.22M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-161.84M

Minimum

Sep 2019

42.47M

Maximum

Jun 2023

-87.58M

Average

-123.02M

Median

Mar 2022

Cash from Operations (TTM) Benchmarks